89 related articles for article (PubMed ID: 17447163)
1. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
[TBL] [Abstract][Full Text] [Related]
2. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.
Kushi A; Sasai H; Koizumi H; Takeda N; Yokoyama M; Nakamura M
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15659-64. PubMed ID: 9861026
[TBL] [Abstract][Full Text] [Related]
3. Reduced capacity for fatty acid oxidation in rats with inherited susceptibility to diet-induced obesity.
Ji H; Friedman MI
Metabolism; 2007 Aug; 56(8):1124-30. PubMed ID: 17618960
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.
Novak CM; Zhang M; Levine JA
Brain Res; 2007 Sep; 1169():57-68. PubMed ID: 17706946
[TBL] [Abstract][Full Text] [Related]
5. Effects of NPY-2 Receptor Antagonists, Semaglutide, PYY
Kloock S; Haerting N; Herzog G; Oertel M; Geiger N; Geier A; Sequeira V; Nickel A; Kohlhaas M; Fassnacht M; Dischinger U
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542814
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs. Current Status.
Moreno-Herrera A; García A; Palos I; Rivera G
Mini Rev Med Chem; 2014 Oct; ():. PubMed ID: 25355591
[TBL] [Abstract][Full Text] [Related]
7. Dietary energy balance modulates prostate cancer progression in Hi-Myc mice.
Blando J; Moore T; Hursting S; Jiang G; Saha A; Beltran L; Shen J; Repass J; Strom S; DiGiovanni J
Cancer Prev Res (Phila); 2011 Dec; 4(12):2002-14. PubMed ID: 21952584
[TBL] [Abstract][Full Text] [Related]
8. Immunization against active ghrelin using virus-like particles for obesity treatment.
Andrade S; Pinho F; Ribeiro AM; Carreira M; Casanueva FF; Roy P; Monteiro MP
Curr Pharm Des; 2013; 19(36):6551-8. PubMed ID: 23859551
[TBL] [Abstract][Full Text] [Related]
9. Npy deletion in an alcohol non-preferring rat model elicits differential effects on alcohol consumption and body weight.
Qiu B; Bell RL; Cao Y; Zhang L; Stewart RB; Graves T; Lumeng L; Yong W; Liang T
J Genet Genomics; 2016 Jul; 43(7):421-30. PubMed ID: 27461754
[TBL] [Abstract][Full Text] [Related]
10. Genetic and dietary effects on dendrites in the rat hypothalamic ventromedial nucleus.
Labelle DR; Cox JM; Dunn-Meynell AA; Levin BE; Flanagan-Cato LM
Physiol Behav; 2009 Oct; 98(4):511-6. PubMed ID: 19698729
[TBL] [Abstract][Full Text] [Related]
11. Protection against overfeeding-induced weight gain is preserved in obesity but does not require FGF21 or MC4R.
Lund C; Ranea-Robles P; Falk S; Rausch DM; Skovbjerg G; Vibe-Petersen VK; Krauth N; Skytte JL; Vana V; Roostalu U; Pers TH; Lund J; Clemmensen C
Nat Commun; 2024 Feb; 15(1):1192. PubMed ID: 38331907
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic DNA 5-hydroxymethylation levels are altered by diet-induced weight gain during the development of obesity in a sex-specific manner.
McFadden T; Carucci I; Farrell K; Fletchall E; Jarome TJ
Brain Res; 2023 Oct; 1817():148478. PubMed ID: 37422205
[TBL] [Abstract][Full Text] [Related]
13. Effects of gastrointestinal motility on obesity.
Fu XY; Li Z; Zhang N; Yu HT; Wang SR; Liu JR
Nutr Metab (Lond); 2014 Jan; 11(1):3. PubMed ID: 24398016
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of hypothalamic TRPV4 via S100a4/AMPKα signaling pathway promotes the development of diet-induced obesity.
Xi P; Zhu W; Zhang Y; Wang M; Liang H; Wang H; Tian D
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166883. PubMed ID: 37683711
[TBL] [Abstract][Full Text] [Related]
15. Rat models of diet-induced obesity and metabolic dysregulation: Current trends, shortcomings and considerations for future research.
Sadie-Van Gijsen H; Kotzé-Hörstmann L
Obes Res Clin Pract; 2023; 17(6):449-457. PubMed ID: 37788944
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of silymarin-loaded chitosan nanoparticles in the diet-induced hyperlipidemia rat model.
Akheratdoost V; Panahi N; Safi S; Mojab F; Akbari G
Iran J Basic Med Sci; 2024; 27(6):725-732. PubMed ID: 38645495
[TBL] [Abstract][Full Text] [Related]
17. Reversal of Obesity by Enhancing Slow-wave Sleep via a Prokineticin Receptor Neural Circuit.
Han Y; Xia G; Harris L; Liu P; Guan D; Wu Q
bioRxiv; 2024 May; ():. PubMed ID: 38746393
[TBL] [Abstract][Full Text] [Related]
18. The Regulatory Role of MicroRNAs in Obesity and Obesity-Derived Ailments.
Benavides-Aguilar JA; Torres-Copado A; Isidoro-Sánchez J; Pathak S; Duttaroy AK; Banerjee A; Paul S
Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003013
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Exosomal miR-452 and miR-4713 Downregulating
Feng X; Ding Y; Zhou M; Song N; Ding Y
Dis Markers; 2022; 2022():2843353. PubMed ID: 35401881
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid system is modulated in reward and homeostatic brain regions following diet-induced obesity in rats: a cluster analysis approach.
Bourdy R; Hertz A; Filliol D; Andry V; Goumon Y; Mendoza J; Olmstead MC; Befort K
Eur J Nutr; 2021 Dec; 60(8):4621-4633. PubMed ID: 34165614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
